제2형 당뇨병 소아 참여자에서 오르포글리프론과 둘라글루타이드의 비교 연구

This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them. Participation in the study will last about 61 weeks.